Poster discussion hub abstracts days was 5% (CI.95 0-11%) and was lower respect to abnormal DV (p<0.05). In the abnormal DV there was an increased risk of abnormal cord blood pH or BE (p<0.05). In the abnormal DV neonatal death was not associated with abnormal cord blood pH or BE at birth. The only significant correlation was between abnormal cord blood pH at birth and neonatal mortality in the normal DV waveform group (p<0.05). No significant differences were found in morbidity between the two groups. Conclusions: This study shows how a normal or abnormal DV does not reduce IUFD, but is related to a worse acid-base status of the fetuses. This result should be considered as the mortality rate may increase in DV abnormalities while this in not significant for morbidity.
Objectives: Uterine artery Doppler (UtAD) is an imperfect screening test for pre-eclampsia (PE) and fetal growth restriction (FGR), with better screening performance for early onset complications. We have shown that maternal cardiac output is lower than healthy pregnancies in women with PE+FGR and FGR and higher than healthy pregnancies in PE. We sought to determine whether UtAD characteristics were different in these groups that are based on maternal hemodynamic function rather than by gestation at onset of disease. Methods: Women between 24-40 weeks gestation were prospectively recruited into 3 groups -pre-eclampsia (PE, n=13), fetal growth restriction with or without pre-eclampsia (FGR/PE+FGR, n=32) and healthy controls (n=62). PE was defined as maternal blood pressure of > 140/90 mmHg and urine protein creatinine ratio of > 30. FGR was defined as fetal abdominal circumference < 10th percentile and umbilical Doppler PI > 95th centile. Those with chronic hypertension or fetal anomaly were excluded. UtAD was performed and mean PI recorded. Results: Mean UtAD PI was significantly raised in FGR/PE+FGR (mean= 1.5, SD= 0.55; P=0.0001) compared to controls (mean=0.8, SD=0.24) but not different in pregnancies with PE only (mean=0.92, SD=0.33; p=1.00). Conclusions: UtAD impedance was higher in FGR/PE+FGR than controls, and no different between PE and controls. This may explain the apparent paradox in the screening performance of UtAD impedance, which appears to be closely related to the conditions associated with low maternal cardiac output-these conditions being most commonly encountered though not exclusively so at early gestation.
Supporting information can be found in the online version of this abstract th and 25 th for EPE and at the 10 th for IUGR at the GA when ultrasound was performed. There is no correlation between the UmbA S/D ratio and the umbilical venous volumetric blood flow in normal pregnancies at the placental end (r 2 = 0.008 p= 0.78) and only minimal correlation at the fetal end (r 2 = 0.04 p=0.04). There was no correlation in the pathological groups either, despite higher resistance and lower flows (LPE r 2 = 0.051 p=0.028, EPE r 2 = 0.24 p = 0.10; IUGR r 2 = 0.023, p=0.16. If all pathologies are considered together, correlation improves (r 2 = 0.09, p = 0.04) but still explains only minimal variation. Conclusions: In normal term pregnancies the UmbA S/D ratios are unrelated to the umbilical venous volumetric blood flow. Higher UmbA resistance in pathologies may be indicative of generally lowered blood flow, but is not directly correlated and one cannot infer that fetal blood flow is more or less compromised with higher or lower resistance index.
